Cure for Stroke Australia (CFSA) was established to achieve a significant impact on improving stroke health outcomes in Australia through research.

We are supporting world-class stroke research to improve prevention, diagnosis and acute treatment to cure stroke.

CFSA supports research undertaken through the Stroke Research Programme (SRP), a unique collaboration between the South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, the Central Adelaide Local Health Network (CALHN) and the Basil Hetzel Institute for Translational Health Research (BHI). The SRP has been instrumental in helping establish dedicated Stroke Treatment Units at major hospitals in Adelaide including the Royal Adelaide Hospital (RAH), The Queen Elizabeth Hospital (TQEH) and the Lyell McEwin Hospital (LMH).  Research conducted by the SRP is helping to improve response times and health outcomes for individuals who have a stroke.  Through innovative research the SRP is also striving to discover new therapies to overcome disability following stroke.

CFSA is a disease specific affiliate of The Hospital Research Foundation (THRF). All donations made to CFSA are directed to stroke research.

To find out more about Cure for Stroke Australia visit the website.

cure for stroke logo

Find out more about Cure for Stroke Australia